INT252167

Context Info Confidence 0.42 First Reported 2008 Last Reported 2008 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.18 Pain Relevance 0.08

Golgi apparatus (COG1)

COG1 (Homo sapiens)

Pain Link Frequency Relevance Heat antidepressant 1 89.48 depression 2 61.24 imagery 39 50.00 positron emission tomography 16 48.80 Hippocampus 8 5.00 corticosteroid 1 5.00 cINOD 1 5.00 anticonvulsant 1 5.00 nMDA receptor 1 5.00 Serotonin 1 5.00

Disease Link Frequency Relevance Heat Cognitive Disorder 4 62.40 Depression 2 61.24 Phobia 1 52.92 Alzheimer's Dementia 34 50.00 Disease 6 5.00 Disorder Of Lipid Metabolism 5 5.00 Frailty 4 5.00 Dementia 2 5.00 Cerebrovascular Disease 1 5.00 Communication Disorders 1 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

The 52-week decline in patients on placebo on the ADAS-Cog, MMSE, CDR and ADCS-ADL was 8.2, 2.0, 0.5 and 5.1 points, respectively.

Negative_regulation (decline) of Cog

1) Confidence 0.42 Published 2008 Journal Journal of Neurology, Neurosurgery, and Psychiatry Section Body Doc Link PMC2582338 Disease Relevance 0.18 Pain Relevance 0.08

General Comments

This test has worked.